A new medicine can cure a rare type of myalgic encephalomyelitis
LEUKOPENIA MEDICINE is the latest in a string of new medicines to be developed by a British company.The new drug, LYTRAZON, is the first to be licensed in the United Kingdom and the first approved for use in the UK.LYTREZON works by targeting the protein of the immune system and targeting the immune cells that […]